MD Anderson Cancer Center

MD Anderson Cancer Center
Name	MD Anderson Cancer Center
Caption	The main campus in the Texas Medical Center
Established	1941
Type	Academic medical center
Affiliation	University of Texas System
City	Houston
State	Texas
Country	United States
Website	www.mdanderson.org

MD Anderson Cancer Center. It is a comprehensive cancer center located in Houston, Texas, and is part of the University of Texas System. Founded in 1941, it is one of the world's most respected institutions devoted exclusively to cancer patient care, research, education, and prevention. The center is consistently ranked among the top hospitals for cancer care in the United States by publications such as U.S. News & World Report.

History

The institution was created by an act of the Texas Legislature in 1941, funded in part by assets from the M.D. Anderson Foundation. It opened its first patient facility in 1944 in a converted house in Houston before moving to its permanent home within the Texas Medical Center in the 1950s. Under the leadership of early directors like R. Lee Clark, the center established its core mission of integrating patient care, research, and education. A pivotal moment in its growth was the passage of the National Cancer Act of 1971, which designated it as one of the original three comprehensive cancer centers.

Organization and leadership

The center operates as a component institution of the University of Texas System, governed by the University of Texas Board of Regents. Its executive leadership is headed by a president, a position held by notable figures such as John Mendelsohn and Peter Pisters. The organization is divided into numerous clinical and research departments, including divisions focused on Cancer Biology, Genomic Medicine, and Translational Research. It maintains formal partnerships with institutions like the University of Texas Health Science Center at Houston and collaborates globally through initiatives such as the MD Anderson Cancer Network.

Patient care and research programs

Patient care is delivered through a multidisciplinary model across more than 20 specialized care centers, such as those for Leukemia, Breast Cancer, and Melanoma. Its research enterprise is vast, encompassing basic science, clinical trials, and prevention studies, with major efforts in Immunotherapy, Precision Oncology, and Proton Therapy. The center operates one of the largest Clinical Trial programs in the nation and is a leader in developing CAR T-cell Therapy. Key research facilities include the Institute for Applied Cancer Science and the Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy.

Education and training

As a degree-granting academic unit of the University of Texas, it offers graduate programs through the University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, a joint venture with UTHealth Houston. Training programs include residencies and fellowships in specialties like Surgical Oncology and Radiation Oncology, accredited by the Accreditation Council for Graduate Medical Education. It also provides extensive continuing education for global health professionals through its Division of Cancer Prevention and Population Sciences and the Center for Global Oncology.

Rankings and recognition

The center has been ranked number one for cancer care in the United States by U.S. News & World Report for multiple years within its "Best Hospitals" survey. It consistently receives high marks in specialty rankings for Adult Leukemia, Lung Cancer Surgery, and Uterine Cancer Surgery. It holds the highest designation, "Comprehensive Cancer Center," from the National Cancer Institute and is a member of the National Comprehensive Cancer Network. Additional accolades include the Magnet Recognition Program award for nursing excellence.

Notable faculty and alumni

The institution has been associated with many pioneering figures in oncology. Notable faculty have included James Allison, a Nobel laureate in Physiology or Medicine for his work in Immunotherapy; John Mendelsohn, who developed targeted therapies like Cetuximab; and Gabriel Hortobagyi, a leader in Breast Cancer research. Distinguished alumni and trainees have gone on to lead major organizations such as the American Society of Clinical Oncology and hold prominent chairs at institutions like Memorial Sloan Kettering Cancer Center and the Dana-Farber Cancer Institute.

Category:University of Texas System Category:Cancer centers in the United States Category:Hospitals in Houston Category:1941 establishments in Texas